We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Tixagevimab and cilgavimab

Australian Public Assessment Report

AusPAR

AusPAR: Tixagevimab/Cilgavimab [PDF, 3.09 MB]

AusPAR: Tixagevimab/Cilgavimab [Word, 8.44 MB]

Attachment: Product Information for Tixagevimab/Cilgavimab [PDF, 211.16 KB]

Attachment: Product Information for Tixagevimab/Cilgavimab [Word, 178.35 KB]

Device/Product Name

Evusheld

Active ingredients

Tixagevimab and cilgavimab

AusPAR Date

8 March 2022

Published

11 March 2022

Submission Number

PM-2021-05375-1-2

Submission Type

New biological entity

Decision

Approved for provisional registration